Copper Radiotheranostics Targeting Fibroblast Activation Protein in Cancer
Author Information
Author(s): Pawan Thapa, Sashi Debnath, Anjan Bedi, Madhuri Parashar, Paulina Gonzalez, Joshua Reus, Hans Hammers, Xiankai Sun
Primary Institution: University of Texas Southwestern Medical Center
Hypothesis
Can a multivalent approach improve the effectiveness of FAP-targeted radiotheranostics?
Conclusion
The study demonstrates that a bifunctional chelator scaffold can enhance the tumor uptake and retention of FAP-targeted radiotheranostic agents.
Supporting Evidence
- The divalent conjugate showed significantly higher FAP-specific tumor uptake than the monovalent counterpart.
- Both conjugates demonstrated high in vitro stability and anticipated FAP-mediated cell binding.
- The BFS-based multivalent approach can be practically used to generate effective cancer diagnosis and treatment agents.
Takeaway
This research shows that using a special design can help deliver cancer treatments more effectively by targeting a specific protein found in tumors.
Methodology
The study involved synthesizing and radiolabeling monovalent and divalent conjugates with 64Cu, followed by in vitro and in vivo evaluations.
Limitations
The study did not optimize the radiolabeling conditions to maximize the molar activity of the radiotheranostic agents.
Statistical Information
P-Value
<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website